This Week’s CGT News: Novo’s Parkinson’s Pivot
May 18, 2026
Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward
6 min read
False
Advertisement
Cell & Gene
Breaking the “Black Box” in Bioprocessing
May 14, 2026
Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development
9 min read
Industrializing Organoids to Bridge the Predictability Gap
By Priya Baraniak
May 11, 2026
As regulators move away from animal testing, scalable organoid platforms and standardized iPSC inputs could help close the gap between preclinical models and human biology
4 min read
This Week’s CGT News: CAR-T Breaks New Ground in Alzheimer’s
May 11, 2026
First CAR-T approach for Alzheimer’s reduces amyloid plaques in mice, while cell and gene therapies advance across blood cancers, retinal disease, amyloidosis, and FSHD
6 min read
Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
Pharma Supply Chains in the Crossfire
May 5, 2026
How tariff uncertainty and geopolitical tensions are reshaping pharmaceutical logistics
6 min read
This Week’s CGT News: CRISPR Hits Phase 3 Milestone
May 4, 2026
Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal
6 min read
Manufacturing Viral Vectors for the Next Phase of CGT
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
Roving Reporter Asks: What Is Your View on the Takeda “U-turn”?
April 29, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to unpack reactions to Takeda’s strategic shift.
Roving Reporter Asks: What Was the Biggest Development in CGT of 2025?
April 22, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs
10 min read
